Literature DB >> 1378698

Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.

N Sugiyama1, S Marcovina, A M Gown, H Seftel, B Joffe, A Chait.   

Abstract

Human xanthomas derived from four subjects with familial hypercholesterolemia (3 homozygotes and 1 heterozygote) were studied by immunohistochemical methods to determine the presence and distribution of lipoproteins, which have been implicated in the pathogenesis of atherosclerosis. Oxidatively modified low-density lipoprotein (OxLDL) epitopes detected with anti-OxLDL monoclonal antibodies, appeared to have a similar distribution in xanthomata to that of macrophages, detected by a cell-specific monoclonal antibody. Double antibody labeling with both an anti-macrophage antibody and an anti-OxLDL antibody demonstrated that OxLDL epitopes are associated with macrophages and occurred intracellularly. Low-density lipoprotein (LDL) epitopes were detected extracellularly, with a distribution that was different from that of OxLDL. In addition, apo(a) epitopes detected by an apo(a) specific monoclonal antibody, had a distribution similar to that of LDL in the dermis and subcutaneous tissues. The observed epitope distribution of LDL, OxLDL, or apo(a) was the same regardless of the method of treatment of the patients from whom the xanthomas were obtained (probucol, simvastatin, LDL apheresis). These findings suggest that OxLDL is likely to play a pathogenetic role in the lipid accumulation by macrophages in xanthomas, and suggest that Lp(a) also may play a role in their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378698      PMCID: PMC1886588     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease.

Authors:  K Berg; G Dahlén; M H Frick
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

3.  The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. 1. The lipids in the isolated fractions.

Authors:  E B Smith; R S Slater
Journal:  Atherosclerosis       Date:  1972 Jan-Feb       Impact factor: 5.162

4.  Lipoprotein Lp(a) and the risk for myocardial infarction.

Authors:  G M Kostner; P Avogaro; G Cazzolato; E Marth; G Bittolo-Bon; G B Qunici
Journal:  Atherosclerosis       Date:  1981 Jan-Feb       Impact factor: 5.162

5.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression.

Authors:  J H Rapp; W E Connor; D S Lin; T Inahara; J M Porter
Journal:  J Lipid Res       Date:  1983-10       Impact factor: 5.922

7.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

Authors:  J W Heinecke; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47.

Authors:  S G Young; J L Witztum; D C Casal; L K Curtiss; S Bernstein
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

10.  Monoclonal antibodies can precipitate low-density lipoprotein. I. Characterization and use in determining apolipoprotein B.

Authors:  S Marcovina; D France; R A Phillips; S J Mao
Journal:  Clin Chem       Date:  1985-10       Impact factor: 8.327

View more
  4 in total

1.  Abnormal lipoprotein(a) levels predict coronary artery calcification in Southeast Asians but not in Caucasians: use of noninvasive imaging for evaluation of an emerging risk factor.

Authors:  Abhinav Sharma; Manoefris Kasim; Parag H Joshi; Zhen Qian; Eric Krivitsky; Kamran Akram; Sarah Rinehart; Gustavo Vazquez; Joseph Miller; Mohammad Saifur Rohman; Szilard Voros
Journal:  J Cardiovasc Transl Res       Date:  2011-04-12       Impact factor: 4.132

2.  Effects of APOE, APOB and LDLR variants on serum lipids and lack of association with xanthelasma in individuals from Southeastern Brazil.

Authors:  Marcelo A Nakazone; Miguel A De Marchi; Marcela A S Pinhel; Carolina F D C Barros; Maysa A F Júlio; Anielli Pinheiro; Simone S Arazi; Júlia K Hotta; Mário H Hirata; Rosario D C Hirata; José E Dos Santos; Dorotéia R S Souza
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

Review 3.  Tendon pathology in hypercholesterolaemia patients: Epidemiology, pathogenesis and management.

Authors:  Yang Yang; Hongbin Lu; Jin Qu
Journal:  J Orthop Translat       Date:  2018-08-06       Impact factor: 5.191

4.  Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study.

Authors:  Masatsune Ogura; Mariko Harada-Shiba; Daisaku Masuda; Hidenori Arai; Hideaki Bujo; Shun Ishibashi; Hiroyuki Daida; Nobuhiko Koga; Shinichi Oikawa; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2021-06-10       Impact factor: 4.394

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.